In today's video, I discuss an artificial intelligence stock focused on agentic solutions, its business strategy, growth ...

UiPath's ARR to reach $1.816B in FY26 amid strong AI automation growth. Explore profitability, valuation, and challenges ...

US-based healthcare software provider Coronis Health has adopted the UiPath Platform from AI solution developer UiPath to ...

EverSource Wealth Advisors LLC raised its stake in UiPath Inc. (NYSE:PATH – Free Report) by 141.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional ...

Learn more about whether Elastic N.V. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare ...

Learn more about whether CCC Intelligent Solutions Holdings Inc. or UiPath Inc. is a better investment based on AAII's A+ ...

We recently published a list of Top 10 Stocks Everyone is Talking About. In this article, we are going to take a look at ...

Canadian investors could consider owning beaten-down AI stocks such as AMD to generate outsized gains in the next 12 months.

UiPath, a leading enterprise automation and AI software company, has announced its annual UiPath Agentic AI Summit will take ...

UiPath to hold Agentic AI Summit on March 25 to demonstrate its latest agentic automation innovations and how UiPath ...

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

UiPath (NYSE:PATH – Free Report) had its price objective cut by Scotiabank from $15.00 to $12.00 in a research report report ...